Published radiopharmaceutical extravasation rate: 15.5% (8 studies, 12 centers, 3354 patients)

  1. Osman, M.M., et al., FDG dose extravasations in PET/CT: frequency and impact on SUV measurements. Front Oncol, 2011. 1: p. 41.
  2. Hall, N., et al., Impact of FDG extravasation on SUV measurements in clinical PET/CT. Should we routinely scan the injection site? J Nucl Med, 2006. 47(suppl 1): p. 115P.
  3. Bains, A., et al., Contamination in 18F-FDG PET/CT: an initial experience. J Nucl Med, 2009. 50 (supplement 2): p. 2222
  4. Krumrey, S., et al., FDG manual injection verses infusion system: a comparison of dose precision and extravasation. J Nucl Med, 2009. 50(supplement 2): p. 2031.
  5. Silva-Rodriguez, J., et al., Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies. Med Phys, 2014. 41(5): p. 052502.
  6. Muzaffar, R., et al., Novel method to detect and characterize (18)F-FDG infiltration at the injection site: a single-institution experience. J Nucl Med Technol, 2017. 45(4): p. 267-271.
  7. McIntosh, C. and J. Abele, Frequency of Interstitial Radiotracer Injection for Patients Undergoing Bone Scan, in The Canadian Association of Radiologists. 2016: Montreal, Quebec.